| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | +Options Exercise | $933,866 | +9,825 | +7.1% | $95.05 | 148,237 | May 23, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$933,949 | -7,376 | -4.98% | $126.62 | 140,861 | May 23, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$122,062 | -964 | -0.68% | $126.62 | 139,897 | May 23, 2022 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $1,054,376 | +10,950 | +7.83% | $96.29 | 150,847 | May 23, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$1,054,491 | -8,328 | -5.52% | $126.62 | 142,519 | May 23, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$130,672 | -1,032 | -0.72% | $126.62 | 141,487 | May 23, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -9,825 | -100% | $0.00 | 0 | May 23, 2022 | Common Stock | 9,825 | $95.05 | Direct | F1 |
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -10,950 | -100% | $0.00 | 0 | May 23, 2022 | Common Stock | 10,950 | $96.29 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in 25% increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |
| F2 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |